Tyra Biosciences (TYRA) analyst forecast and price target
Analyst forecast
Consensus of 15 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Jones Trading | Initiated Coverage | Buy | $56.00 | Jun 17, 2026 |
| B of A Securities | Maintained | Buy | $42.00 from $37.00 | Jun 10, 2026 |
| Wolfe Research | Initiated Coverage | Peer Perform | — | May 19, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $45.00 | May 14, 2026 |
| Guggenheim | Initiated Coverage | Buy | $54.00 | Apr 15, 2026 |
| Canaccord Genuity | Initiated Coverage | Buy | $50.00 | Apr 6, 2026 |
| Piper Sandler | Maintained | Overweight | $56.00 from $42.00 | Mar 20, 2026 |
| Cantor Fitzgerald | Initiated Coverage | Overweight | — | Feb 24, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $45.00 from $30.00 | Feb 17, 2026 |
| Wedbush | Maintained | Outperform | $53.00 from $37.00 | Feb 13, 2026 |
| Jefferies | Maintained | Buy | $43.00 from $32.00 | Feb 3, 2026 |
| Oppenheimer | Maintained | Outperform | $50.00 from $36.00 | Feb 3, 2026 |
| Barclays | Initiated Coverage | Overweight | $59.00 | Jan 28, 2026 |
| Piper Sandler | Maintained | Overweight | $42.00 from $33.00 | Jan 23, 2026 |
| Wedbush | Maintained | Outperform | $37.00 from $30.00 | Dec 16, 2025 |
| Raymond James | Initiated Coverage | Strong Buy | $35.00 | Sep 3, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $30.00 | Aug 22, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $30.00 | Jul 1, 2025 |
| Piper Sandler | Initiated Coverage | Overweight | $33.00 | May 21, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $30.00 | Mar 31, 2025 |
Frequently asked questions
Is TYRA a buy, sell, or hold?
Analysts covering Tyra Biosciences currently average a Buy rating: 14 buy, 1 hold and 0 sell, from 15 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on TYRA?
On Jun 17, 2026, Jones Trading initiated coverage of Tyra Biosciences at Buy with a price target of $56.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.